IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,823,481 | -26.6% | 15,174,000 | -22.9% | 0.07% | -33.0% |
| Q2 2023 | $20,183,573 | +58.1% | 19,674,000 | +55.2% | 0.10% | +53.8% |
| Q1 2023 | $12,763,623 | -48.6% | 12,674,000 | -44.1% | 0.06% | -64.1% |
| Q4 2022 | $24,842,201 | +7.3% | 22,674,000 | 0.0% | 0.18% | +29.3% |
| Q3 2022 | $23,142,000 | -6.4% | 22,674,000 | 0.0% | 0.14% | +15.7% |
| Q2 2022 | $24,715,000 | -8.3% | 22,674,000 | 0.0% | 0.12% | +63.5% |
| Q1 2022 | $26,948,000 | +97.7% | 22,674,000 | +90.5% | 0.07% | +221.7% |
| Q4 2021 | $13,629,000 | – | 11,903,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 35,225,000 | $39,760,000 | 1.94% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,079,000 | $4,662,000 | 0.54% |
| AQR Arbitrage LLC | 11,500,000 | $13,038,000 | 0.47% |
| Context Capital Management, LLC | 3,934 | $4,460,000 | 0.44% |
| Polar Asset Management Partners Inc. | 7,000,000 | $7,938,000 | 0.08% |
| Calamos Advisors LLC | 9,500,000 | $10,748,000 | 0.06% |
| LINDEN ADVISORS LP | 6,201,000 | $7,007,000 | 0.05% |
| LAZARD ASSET MANAGEMENT LLC | 14,500,000 | $16,439,000 | 0.02% |
| Citadel Advisors | 68,788,000 | $77,681,000 | 0.02% |
| PUTNAM INVESTMENTS LLC | 7,976,000 | $9,002,000 | 0.02% |